Literature DB >> 16129699

Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats.

Sophie Lanone1, Sébastien Bloc, Roberta Foresti, Abdelhamid Almolki, Camille Taillé, Jacques Callebert, Marc Conti, Delphine Goven, Michel Aubier, Bertrand Dureuil, Jamel El-Benna, Roberto Motterlini, Jorge Boczkowski.   

Abstract

We investigated a possible beneficial role for bilirubin, one of the products of heme degradation by the cytoprotective enzyme heme oxygenase-1 in counteracting Escherichia coli endotoxin-mediated toxicity. Homozygous jaundice Gunn rats, which display high plasma bilirubin levels due to deficiency of glucuronyl transferase activity, and Sprague-Dawley rats subjected to sustained exogenous bilirubin administration were more resistant to endotoxin (LPS)-induced hypotension and death compared with nonhyperbilirubinemic rats. LPS-stimulated production of nitric oxide (NO) was significantly decreased in hyperbilirubinemic rats compared with normal animals; this effect was associated with reduction of inducible NO synthase (NOS2) expression in renal, myocardial, and aortic tissues. Furthermore, NOS2 protein expression and activity were reduced in murine macrophages stimulated with LPS and preincubated with bilirubin at concentrations similar to that found in the serum of hyperbilirubinemic animals. This effect was secondary to inhibition of NAD(P)H oxidase since 1) inhibition of NAD(P)H oxidase attenuated NOS2 induction by LPS, 2) bilirubin decreased NAD(P)H oxidase activity in vivo and in vitro, and 3) down-regulation of NOS2 by bilirubin was reversed by addition of NAD(P)H. These findings indicate that bilirubin can act as an effective agent to reduce mortality and counteract hypotension elicited by endotoxin through mechanisms involving a decreased NOS2 induction secondary to inhibition of NAD(P)H oxidase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16129699     DOI: 10.1096/fj.04-2368fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  82 in total

Review 1.  NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease.

Authors:  J Haslund-Vinding; G McBean; V Jaquet; F Vilhardt
Journal:  Br J Pharmacol       Date:  2016-02-26       Impact factor: 8.739

2.  Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II-dependent hypertension.

Authors:  David E Stec; Luis A Juncos; Joey P Granger
Journal:  J Am Soc Hypertens       Date:  2016-01-30

3.  Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis.

Authors:  Domenico Lapenna; Giuliano Ciofani; Sante Donato Pierdomenico; Maria Adele Giamberardino; Sante Ucchino; Giovanni Davì
Journal:  Clin Exp Med       Date:  2017-09-25       Impact factor: 3.984

4.  Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase.

Authors:  Stephen D Zucker; Megan E Vogel; Tammy L Kindel; Darcey L H Smith; Gila Idelman; Uri Avissar; Ganesh Kakarlapudi; Michelle E Masnovi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-17       Impact factor: 4.052

5.  Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?

Authors:  Terry D Hinds; Samuel O Adeosun; Abdulhadi A Alamodi; David E Stec
Journal:  Med Hypotheses       Date:  2016-08-31       Impact factor: 1.538

Review 6.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

7.  D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.

Authors:  Quansheng Lu; Yu Yang; Van Anthony Villar; Laureano Asico; John E Jones; Peiying Yu; Hewang Li; Edward J Weinman; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertens Res       Date:  2013-02-21       Impact factor: 3.872

8.  Antihypertensive actions of moderate hyperbilirubinemia: role of superoxide inhibition.

Authors:  David E Stec; Megan V Storm; Brandon E Pruett; Monette U Gousset
Journal:  Am J Hypertens       Date:  2013-03-12       Impact factor: 2.689

9.  Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans.

Authors:  Abdelhamid Almolki; Armelle Guenegou; Slawomir Golda; Laurent Boyer; Mourad Benallaoua; Nadia Amara; Rafik Bachoual; Clémence Martin; François Rannou; Sophie Lanone; Jozef Dulak; Pierre-Régis Burgel; Jamel El-Benna; Benedicte Leynaert; A Benedicte Leynaert; Michel Aubier; Jorge Boczkowski
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

10.  Kidney-specific induction of heme oxygenase-1 prevents angiotensin II hypertension.

Authors:  Trinity Vera; Silvia Kelsen; David E Stec
Journal:  Hypertension       Date:  2008-08-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.